PA8488001A1 - Derivados 3-azabiciclo [3.1.0.]hexano utiles en terapia - Google Patents
Derivados 3-azabiciclo [3.1.0.]hexano utiles en terapiaInfo
- Publication number
- PA8488001A1 PA8488001A1 PA19998488001A PA8488001A PA8488001A1 PA 8488001 A1 PA8488001 A1 PA 8488001A1 PA 19998488001 A PA19998488001 A PA 19998488001A PA 8488001 A PA8488001 A PA 8488001A PA 8488001 A1 PA8488001 A1 PA 8488001A1
- Authority
- PA
- Panama
- Prior art keywords
- useful
- azabiciclo
- hexane
- therapy
- derivatives
- Prior art date
Links
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 title 3
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9828485.4A GB9828485D0 (en) | 1998-12-23 | 1998-12-23 | Compounds useful in therapy |
| GBGB9912425.7A GB9912425D0 (en) | 1999-05-27 | 1999-05-27 | Compounds useful in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8488001A1 true PA8488001A1 (es) | 2002-10-28 |
Family
ID=40257194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA19998488001A PA8488001A1 (es) | 1998-12-23 | 1999-12-23 | Derivados 3-azabiciclo [3.1.0.]hexano utiles en terapia |
Country Status (10)
| Country | Link |
|---|---|
| KR (1) | KR100504647B1 (fr) |
| AR (1) | AR035157A1 (fr) |
| CO (1) | CO5261495A1 (fr) |
| IL (1) | IL142697A (fr) |
| MY (1) | MY130771A (fr) |
| PA (1) | PA8488001A1 (fr) |
| PE (1) | PE20001318A1 (fr) |
| PT (1) | PT1140828E (fr) |
| RS (1) | RS50051B (fr) |
| TN (1) | TNSN99235A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101454297B (zh) | 2006-05-31 | 2012-10-31 | 弗·哈夫曼-拉罗切有限公司 | 芳基-4-乙炔基-异*唑衍生物 |
-
1999
- 1999-11-19 MY MYPI99005067A patent/MY130771A/en unknown
- 1999-11-19 RS YUP-415/01A patent/RS50051B/sr unknown
- 1999-11-19 KR KR10-2001-7008062A patent/KR100504647B1/ko not_active Expired - Fee Related
- 1999-11-19 PT PT99954290T patent/PT1140828E/pt unknown
- 1999-12-08 TN TNTNSN99235A patent/TNSN99235A1/fr unknown
- 1999-12-22 PE PE1999001310A patent/PE20001318A1/es not_active Application Discontinuation
- 1999-12-23 CO CO99080388A patent/CO5261495A1/es not_active Application Discontinuation
- 1999-12-23 AR ARP990106728A patent/AR035157A1/es unknown
- 1999-12-23 PA PA19998488001A patent/PA8488001A1/es unknown
-
2001
- 2001-04-19 IL IL142697A patent/IL142697A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| YU41501A (sh) | 2004-03-12 |
| KR20010086462A (ko) | 2001-09-12 |
| PE20001318A1 (es) | 2000-12-01 |
| IL142697A (en) | 2009-05-04 |
| TNSN99235A1 (fr) | 2005-11-10 |
| RS50051B (sr) | 2008-11-28 |
| PT1140828E (pt) | 2006-12-29 |
| CO5261495A1 (es) | 2003-03-31 |
| MY130771A (en) | 2007-07-31 |
| AR035157A1 (es) | 2004-05-05 |
| KR100504647B1 (ko) | 2005-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2162942T3 (es) | Nuevos derivados de acidos carboxilicos, su obtencion y empleo. | |
| ES2194314T3 (es) | Derivados de benzopirano sustituidos para el tratamiento de inflamaciones. | |
| CO4930259A1 (es) | Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen | |
| ES2058185T3 (es) | Derivados de camptotecina y procedimiento para su preparacion. | |
| BG104247A (en) | Resorcinol derivatives | |
| ES2196377T3 (es) | Derivados de naftiridina. | |
| ES2161290T3 (es) | Derivados de quinazolina. | |
| ES2167377T3 (es) | Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos. | |
| AR023727A1 (es) | Compuestos empleados en el tratamiento de padecimientos inflamatorios | |
| AR003955A1 (es) | Derivados de n-(indol-2-carbonil)-glicinamidas, procedimiento para su obtencion y composiciones que los contienen. | |
| GT199700015A (es) | Inhibidores de metaloproteinasa, composiciones farmaceuticas que las contienen y su uso farmaceutico y metodosyeficazproducto intermedio para su preparacion. | |
| ES2138691T3 (es) | Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina. | |
| TR199901765T2 (xx) | S�lfomid-metalloproteaz inhibit�rleri | |
| ES2181766T3 (es) | Analogos de delda 12,13-isotaxol, uso antineoplasico y composiciones farmaceuticas que los contienen. | |
| NO965516L (no) | Sterolderivater anvendt til regulering av meiose | |
| MX9503529A (es) | Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen. | |
| ES2172937T3 (es) | 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides. | |
| IT1285770B1 (it) | Composti corticoidei | |
| ES2160602T3 (es) | Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria. | |
| AR021843A1 (es) | Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion. | |
| ES2151168T3 (es) | N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
| AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
| ES2135722T3 (es) | 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina. | |
| ES2116496T3 (es) | Proceso para la preparacion de 1,4-disubstituido-5(4h)-tetrazolinonas. |